You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 16, October 22, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Telomeres, cancer, and aging. Altering the human life span

D. A. Banks and M. Fossel
Richard & Rhoda Goldman School of Public Policy & Center for the Economics and Demography of Aging, University of California, Berkeley, USA.

Population projections of the aging global society and its fiscal and social impact have depended on assumptions regarding the human life span. Until now, the assumption that the maximum human life span is fixed has been justified. Recent advances in cell biology, genetics, and our understanding of the cellular processes that underlie aging, however, have shown that this assumption is invalid in a number of animal models and suggest that this assumption may become invalid for humans as well. In vitro alteration of telomeres affects cellular senescence, and in vivo manipulation of genes and diet can increase maximum life span in animal models if these discoveries are extended to humans. We may soon be able to extend the maximum human life span and postpone or prevent the onset of diseases associated with aging. Such a possibility requires that we recognize a growing uncertainty in any attempt to project international health care costs into the next few decades. The costs may be significantly lower than projections, if life span increases and age-related disabilities are postponed or less severe, or perhaps higher, if life span increases without altering the onset and severity of disability. An appropriate uncertainty regarding the human life span undermines any attempt to accurately predict health costs in the next century.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cell Senescence in Human Aging and Disease
FOSSEL
Ann. N. Y. Acad. Sci. 2002;959:14-23.
ABSTRACT | FULL TEXT  

Atherosclerosis and Cancer: Common Molecular Pathways of Disease Development and Progression
ROSS et al.
Ann. N. Y. Acad. Sci. 2001;947:271-293.
ABSTRACT | FULL TEXT  

Telomerase and the Aging Cell: Implications for Human Health
Fossel
JAMA 1998;279:1732-1735.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.